BioCentury
ARTICLE | Clinical News

Morphelan once daily morphine: Phase III

December 21, 1998 8:00 AM UTC

Elan Corp. plc (ELN), Dublin, Ireland Product: Morphelan once daily morphine Indication: Treat pain Status: ELN began Phase III testing, with an NDA submission expected in the fourth quarter of 1999....